The warehouse is a lagging indicator — clearances reflect ~12–18 months of prior R&D and regulatory work. This page carries the leading edge: wire-service and registry signals, refreshed with the nightly pipeline, each source going live as its feed comes online.
Warehouse data is a lagging indicator — clearances reflect ~12–18 months of prior R&D and regulatory work. These sources carry the leading edge; each goes live here as its feed comes online.
| Date | Signal | Firm |
|---|---|---|
| 2026-08-28 |
Philips Korea and HoneyNaps Sign Strategic MOU to Advance Sleep and Cardiovascular Health
Partnership will explore new healthcare opportunities arising from the link between sleep disorders and cardiovascular disease Collaboration to span the integration of sleep data with cardiovascular risk factors, academic initiatives, and more Philips' health technology expertise |
— |
| 2026-08-28 |
Invitation to presentation of Sectra's three-month report 2026/2027
LINKÖPING, Sweden, Aug. 28, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites investors, analysts, and the media to a presentation of the company's three-month report with President Torbjörn Kronander and CFO Jessica Holm |
— |
| 2026-08-28 |
Leo Cancer Care Announces Commercial Collaboration with Leading Healthcare Solutions Provider to Bring Connected Imaging and Radiation Therapy Workflows to Market
MIDDLETON, Wis., Aug. 28, 2026 /PRNewswire/ -- Leo Cancer Care, a pioneer in upright radiation therapy, today announced a commercial collaboration with GE HealthCare, a leading healthcare solutions provider. Under the agreement, the two companies intend to work together on GE Hea |
— |
| 2026-08-28 |
Singclean 2nd Leaders Summit Charts New Course in Global Aesthetics
SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Hosted within the IMCAS China Conference venue at W Shanghai - The Bund, Singclean 2nd International Medical Aesthetic Leaders Summit themed "Global Vision, Embark on a New Chapter" came to a successful conclusion. Gathering top global doct |
— |
| 2026-08-27 |
ROBERT H. GREGG II, DDS, HONORED BY CITY OF CERRITOS FOR BUSINESS LEADERSHIP AND COMMUNITY IMPACT
City Proclamation Recognizes Contributions to Patient Care, Dental Innovation, Clinician Education and Community Service CERRITOS, Calif., Aug. 27, 2026 /PRNewswire/ -- Robert H. Gregg II, DDS, Founder, President and Chairman of the Board of Millennium Dental Technologies, Inc. a |
— |
| 2026-08-27 |
China's 1st Full-stack MRI-Based BCI Solution Released in Tianjin
TIANJIN, China, Aug. 27, 2026 /PRNewswire/ -- China's first National Conference on MRI-Based Brain-Computer Interfaces (BCIs) was held in Tianjin on August 23, 2026, bringing together about 400 experts and representatives from academia, hospitals, leading companies and regulatory |
— |
| 2026-08-27 |
NYU Langone Health Names Sunil Rao, MD, Director of the Leon H. Charney Division of Cardiology and Welcomes Susheel Kodali, MD, to Lead Interventional Cardiology
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney Di |
— |
| 2026-08-27 |
Společnost Biosidus rozšiřuje výrobní kapacitu biologických léčiv a posiluje globální dodavatelské kapacity pro agalsidázu beta
BUENOS AIRES, Argentina, 27. srpna 2026 /PRNewswire/ -- Argentinská biotechnologická společnost Biosidus, která má více než čtyřicetileté zkušenosti s vývojem a výrobou biosimilárních léčivých přípravků, oznámila, že její nový závod s bioreaktory byl uveden do provozu. Společnost |
— |
| 2026-08-27 |
New Real-World Data Show penKid Adding Decision Support for Kidney Replacement Therapy in Critical Care
In a prospective, real-world study of 1,436 critically ill ICU patients, proenkephalin A 119–159 (penKid) provided clinically relevant information across AKI severity and during kidney replacement therapy (KRT). PenKid addressed a key unmet need in KRT management by identifying, |
— |
| 2026-08-27 |
Bittium launches new Faros Pro™ ECG device and EasyFlex™ single-use electrode patch for long-term ambulatory ECG monitoring
Bittium Corporation press release on August 27, 2026, at 9.00 am OULU, Finland, Aug. 27, 2026 /PRNewswire/ -- Bittium today launches Bittium Faros Pro™, a new ambulatory ECG device designed for long-term ECG recording, together with Bittium EasyFlex™, a single-use one-lead electr |
— |
| 2026-08-27 |
Biosidus расширяет мощности по производству биопрепаратов и укрепляет глобальные возможности поставок агалсидазы бета
БУЭНОС-АЙРЕС, Аргентина, 27 августа 2026 г. /PRNewswire/ -- Аргентинская биотехнологическая компания Biosidus, обладающая более чем сорокалетним опытом разработки и производства биоаналогичных лекарственных препаратов, объявила о том, что ее новый биореакторный завод в настоящее |
— |
| 2026-08-27 |
Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems
TAIPEI, Aug. 26, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade |
— |
| 2026-08-27 |
Biosidus amplía su capacidad de fabricación de productos biológicos
-Biosidus amplía su capacidad de fabricación de productos biológicos y refuerza su capacidad de suministro global de agalsidasa beta BUENOS AIRES, Argentina, 27 de agosto de 2026 /PRNewswire/ -- Biosidus, una empresa argentina de biotecnología con más de cuatro décadas de experie |
— |
| 2026-08-27 |
Biosidus erweitert seine Produktionskapazitäten für Biologika und stärkt seine weltweiten Lieferkapazitäten für Agalsidase beta
BUENOS AIRES, Argentinien, 27. August 2026 /PRNewswire/ -- Biosidus, ein argentinisches Biotechnologieunternehmen mit mehr als vier Jahrzehnten Erfahrung in der Entwicklung und Herstellung von Biosimilar-Arzneimitteln, gab bekannt, dass seine neue Bioreaktor-Anlage nun in Betrieb |
— |
| 2026-08-27 |
IBA reports Half Year 2026 results, on track with its improved profitability trajectory
Louvain-la-Neuve, Belgium, 27 August 2026, 7 a.m. - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY 2026 guidance and continued progress towards its profitability improvement trajectory. The |
— |
| 2026-08-27 |
IBA publie ses résultats semestriels 2026, et confirme sa trajectoire d’amélioration de la rentabilité
Louvain-La-Neuve, Belgique, 27 août 2026, 7h00 - IBA (Ion Beam Applications S.A.), annonce aujourd’hui ses résultats consolidés pour le premier semestre 2026, avec une performance conforme aux prévisions pour l’exercice 2026 et des progrès continus dans sa trajectoire d’améliorat |
— |
| 2026-08-27 |
Au Royaume-Uni, le NICE publie des recommandations préconisant le financement systématique par le NHS du système de perfusion hypothermique oxygénée VitaSmart™ de Bridge to Life
DULUTH, Géorgie et LONDRES, 28 août 2026 /PRNewswire/ -- Bridge to Life™ Ltd., leader mondial des solutions de préservation des organes et des technologies de perfusion, souligne aujourd'hui la publication récente de nouvelles recommandations pour les technologies de la santé par |
— |
| 2026-08-27 |
/C O R R E C T I O N -- Bridge to Life, Ltd./
In the news release, UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion System, issued 27-Aug-2026 by Bridge to Life, Ltd. over PR Newswire, we are advised by the company that changes have been made. The compl |
— |
| 2026-08-27 |
UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion System
DULUTH, Ga, and LONDON, Aug. 27, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of new HealthTech guidance by the United Kingdom's National Institute for Health and Care E |
— |
| 2026-08-27 |
Laser by Aleya Experts Explain How Technology and Expertise Make Laser Hair Removal Safer for Dark Skin
GREAT NECK, N.Y., Aug. 27, 2026 /PRNewswire/ -- For years, many people with deeper skin tones were told that laser hair removal was unsafe or less effective for them. Advances in laser technology and treatment protocols have expanded safer treatment options for deeper skin tones, |
— |
| 2026-08-27 |
Memorial Hospital Miramar Opens New Outpatient Facility, Expanding Access to Advanced Imaging and Specialty Care
MIRAMAR, Fla., Aug. 27, 2026 /PRNewswire/ -- Memorial Hospital Miramar has opened a new outpatient facility designed to expand access to advanced diagnostic imaging, outpatient services, specialty care and surgical services for patients and families in the Miramar community and.. |
— |
| 2026-08-27 |
Florida's First Pediatric Cardiac Robotic Surgery Performed at Nicklaus Children's Hospital
Cardiovascular Surgeons within Nicklaus Children's Hospital Heart Institute Have Completed the First Robotics-Assisted Atrial Septal Defect (ASD) Repair in Florida and One of Few in the Nation MIAMI, Aug. 27, 2026 /PRNewswire/ -- The cardiovascular surgery team at Nicklaus Childr |
— |
| 2026-08-27 |
Groundbreaking Healthcare Training Provider Launches 48 Week Associate Degree in Medical Assisting, Breaking the Mold on the Two-Year Associate Degree
The College of Health Care Professions unveils new accelerated Medical Assistant Associate designed for learners to complete full 61.5 credits in under a year. HOUSTON, August 27, 2026 /PRNewswire/ -- The College of Health Care Professions (CHCP) today announced the launch of an. |
— |
| 2026-08-27 |
Metriport Raises $26 million to Give Clinicians Insight into Any Patient Question at the Point of Care
The company turns scattered, fragmented patient records into structured information that gives clinicians what they need, exactly when they need it, to provide the best possible care. SAN FRANCISCO, Aug. 27, 2026 /PRNewswire/ -- Metriport has raised $26 million in new funding to |
— |
| 2026-08-27 |
BioVid Launches Tumor Worlds™: A Strategic Intelligence System to Decode the Behavioral Logic of Oncology Markets
BRISTOL, Pa., Aug. 27, 2026 /PRNewswire/ -- BioVid, a leading life science consultancy, today announced the launch of Tumor Worlds™, a proprietary strategic intelligence system that helps pharmaceutical companies anticipate how oncology markets respond to new evidence. Integratin |
— |
| 2026-08-27 |
AssureCare's Carlton Rodrigo Named to Cincinnati Business Courier's 2026 '40 Under 40'
A ten-year journey at AssureCare, four promotions, a leader who has been raising the bar since day one. CINCINNATI, Aug. 27, 2026 /PRNewswire/ -- AssureCare®, a leading AI-powered population health management company, today announced that Carlton Rodrigo, Senior Director of Accou |
— |
| 2026-08-27 |
Kowa Pharmaceuticals America Announces FDA Acceptance of New Drug Application for K-911, an Investigational IOP-Lowering Eye Drop for Patients with Open-Angle Glaucoma or Ocular Hypertension
Investigational K-911 is a once-daily nitric oxide-donating bimatoprost eye drop designed to lower intraocular pressure NDA is supported by two pivotal Phase 3 trials FDA assigns PDUFA target action date of April 30, 2027 MONTGOMERY, Ala., Aug. 27, 2026 /PRNewswire/ -- Kowa... |
— |
| 2026-08-27 |
Connecting clinical knowledge with care delivery: NCODA and Cureety partner to bring trusted regimen guidance at the point of care
Collaboration brings evidence-based patient education and regimen resources into Cureety's oncology care platform to support informed, patient-centered care. CAZENOVIA, N.Y. and PARIS, Aug. 27, 2026 /PRNewswire/ -- NCODA and Cureety, an oncology-specialized digital health platfor |
— |
| 2026-08-27 |
Innovation durch Zusammenarbeit macht Precision BioLogic zu einem festen Begriff in der Diagnostik und Forschung im Bereich der Hämostase
HALIFAX, NS, 27. August 2026 /PRNewswire/ -- Das gebündelte Fachwissen von Precision BioLogic Inc., einem führenden Entwickler von Diagnostikprodukten für die Hämostase, und dessen Tochtergesellschaften Affinity Biologicals sowie George King Bio-Medical, zieht die Aufmerksamkeit |
— |
| 2026-08-27 |
Body Composition Analyzers Market worth $1.39 billion by 2031 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 27, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Body Composition Analyzers Market is projected to reach USD 1.39 billion by 2031 from USD 0.99 billion in 2026, at a CAGR of 7.1% during the forecast period. Browse 300 market data Tables and 5 |
— |
New trial starts and registry updates — a strong leading indicator for where R&D money is being spent.
MD&M, RSNA, AAOS, AAOMS, ADA, ASCO, HIMSS, CES Health. Next-30-days view of firms exhibiting and what they're launching — real-time signal of where the booth budget is going.
MedTech Dive, MassDevice, MedCity News, MD+DI editorial + SEC 8-K M&A filings. Concurrent and retrospective context.
| Date | Signal | Firm |
|---|---|---|
| 2026-07-26 |
AI device authorizations: what the FDA record shows
FDA authorizations for AI-enabled imaging software grew twentyfold from 2018 to 2025 — then flattened in 2026. Every count queried from openFDA, query… |
— |
| 2026-07-26 |
What a 510(k) clearance does not guarantee a buyer
A 510(k) clearance makes an AI device legal to sell — not clinically superior or commercially proven. The four gaps category buyers have to close themselves. |
— |
| 2026-07-26 |
FDA cleared vs approved vs granted vs registered
Cleared, approved, granted, and registered mean very different things at the FDA. What each proves about an AI tool, and how to verify any claim yourself. |
— |
| 2026-07-25 |
Introducing Insights
Welcome to Insights, the new analysis section of Elephant Hawk. Each week we publish a short, data-driven read on the medtech regulatory landscape — built… |
— |